Rocky Hill, CT, United States of America

Dino C Miano

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Alexion Pharmaceuticals, Inc.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dino C Miano. Retrieved from https://idiyas.com/inventor/dino-c-miano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Dino Miano

Introduction

Dino Miano is an accomplished inventor based in Rocky Hill, Connecticut. He has made significant contributions to the field of pharmaceuticals, particularly in the development of liquid formulations for therapeutic applications.

Latest Patents

Miano holds a patent for "Liquid formulations of anti-CD200 antibodies." This patent provides stable liquid pharmaceutical formulations comprising anti-CD200 antibodies or antigen-binding fragments thereof. The formulations are designed for use in cancer and autoimmune therapies, as well as for preventing, delaying, or treating cell, tissue, or organ transplant rejection.

Career Highlights

Dino Miano is currently employed at Alexion Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing advanced therapeutic solutions that address critical medical needs.

Collaborations

Miano collaborates with various professionals in his field, including his coworker Bruce Mason. Together, they contribute to the advancement of pharmaceutical research and development.

Conclusion

Dino Miano's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions, particularly in the area of anti-CD200 antibodies, highlight the importance of research in developing effective therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…